Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis

Ümit Tapan, David C. Seldin, Kathleen T. Finn, Salli Fennessey, Anthony C Shelton, Jerome B. Zeldis, Vaishali Sanchorawala

Blood · 2010 · 74 citations · 6 references

DOIFull text

Open access

Concepts

Abstract

To the editor: The combination of lenalidomide and dexamethasone can produce hematologic responses in previously treated patients with AL amyloidosis.[1][1] Since this prospective study (ClinicalTrials.gov: [NCT00091260][2]) was initiated, NT-proBNP and BNP have been found to be useful biomarkers

References

6